Sector: Indices SP 400
Latest Quote @ Sat May 5 12:57:33 (15 min delayed)
Last Day's Data
Thoratec Corporation manufactures circulatory support products for use by patients with congestive heart failure. The company operates in two segments, Cardiovascular and International Technidyne Corporation (ITC). The Cardiovascular segment develops, manufactures, and markets medical devices used for circulatory support products, which include ventricular assist device for the short-term and long-term treatment of congestive heart failure, as well as vascular graft products for use as a shunt between an artery and a vein. It offers a product portfolio of implantable and external circulatory support product devices, including the Thoratec Implantable Ventricular Assist Device, a biventricular implantable blood pump; the HeartMate Left Ventricular Assist System (LVAS), an implantable device for mid to long-term cardiac support for those patients ineligible for heart transplantation; and the HeartMate II, an implantable LVAS consisting of a miniature rotary blood pump that is designed to provide long-term support. These products are sold into the hospital point-of-care (POC) market, and the alternate site POC market comprising physician's offices, long-term care facilities, clinics, visiting nurse associations, and home healthcare companies. ITC segment designs, develops, manufactures, and markets point-of-care diagnostic test systems that monitor a patient while being administered certain anticoagulants, blood gas/electrolyte, and chemistry status or anemia; and incision products to obtain a patient's blood sample for diagnostic testing and screening for platelet function. The company markets its products through direct sales force and distributors in the United States, Canada, France, Germany, Spain, the United Kingdom, Austria, Switzerland, the Netherlands, Portugal, and South Africa. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.